title: Adenoid cystic carcinoma of the salivary glands: a review of 10 years.
abstract: A retrospective analysis was performed of 50 patients with adenoid cystic carcinoma who were seen in the Department of Radiation Oncology, University of Witwatersrand, Johannesburg, South Africa, in the past 10 years. There were 25 men and 25 women with a mean age of 52 years (age range, 21 to 88 years). Five patients had metastatic disease, and 17 had neural invasion. Thirty-four patients had surgery (11, complete; 23, microscopic residual). Sixteen patients had radiotherapy as initial management. The disease-free survival was 26%, overall survival was 29%, and local control was 30% at 10 years. Most recurrences occurred in the first 3 years. Nine patients had metastasis following treatment. The mean survival after metastasis was 15 months. Seven prognostic variables were analyzed using the log-rank test. There was no impact of age, site, type of salivary gland (major vs. minor), tumor stage, node positivity, or neural invasion on disease-free survival, overall survival, or local control. Extent of surgical resection (complete vs. microscopic residual) had a significant impact on disease-free survival and local control (P < 0.05) but no impact on overall survival (P > 0.05) because of the slow-growing nature of these tumors. Similarly, patients who had microscopic residual after surgery and were treated with radiotherapy did better than those who had biopsy and radiotherapy, although this was not significant statistically (P > 0.05). Thus, whenever possible, every attempt must be made to remove all microscopic tumor by surgery. Addition of postoperative radiotherapy with high-energy photons did not improve the locoregional control or survival in our series. There is a place for neutrons in the treatment of adenoid cystic carcinomas in advanced cases of inoperable or recurrent tumors, as a review of literature shows.
authors.affiliation: Department of Radiation Oncology, University of the Witwatersrand, South African Institute of Medical Research, Johannesburg.
authors.forename: R K
authors.initials: RK
authors.lastname: Sur
authors.forename: B
authors.initials: B
authors.lastname: Donde
authors.forename: V
authors.initials: V
authors.lastname: Levin
authors.forename: J
authors.initials: J
authors.lastname: Pacella
authors.forename: J
authors.initials: J
authors.lastname: Kotzen
authors.forename: K
authors.initials: K
authors.lastname: Cooper
authors.forename: M
authors.initials: M
authors.lastname: Hale
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D001706:Biopsy; D003528:Carcinoma, Adenoid Cystic / Q000532:radiotherapy / Q000556:secondary / Q000601:surgery / Q000628:therapy*; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D016014:Linear Models; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local / Q000473:pathology; D009367:Neoplasm Staging; D018365:Neoplasm, Residual / Q000473:pathology; D009502:Neutrons / Q000627:therapeutic use; D017785:Photons / Q000627:therapeutic use; D011379:Prognosis; D018714:Radiotherapy, Adjuvant; D012189:Retrospective Studies; D012468:Salivary Gland Neoplasms / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D012469:Salivary Glands / Q000473:pathology; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome